Digital patient solutions to enable clinical trials, anywhere
Powered by our enterprise platform and connected device ecosystem, we provide scalable, comprehensive decentralized clinical trial solutions that enhance participant engagement and alleviate site burden.
Build patient-centric, diversified clinical trials partner with Biofourmis today.
Setting the standard for care, anywhere.
Configurable Platform
Cloud-based infrastructure and data science capabilities serve as the foundation for personalized and scalable solutions that adapt to the needs of your clinical trial programs.
Cellular-enabled device integrations for continuous and episodic data collection
Machine-learning analytics engine for development and implementation of participant-centric algorithms
In-home services coordination capabilities
User-friendly dashboard and communication interface for participants and trial personnel
Remote patient management
Extend trial participation beyond traditional settings, with solutions that enable hybrid or fully decentralized programs.
Digital patient tools including eConsent, ePRO, remote data capture, and virtual visits
Device-agnostic ecosystem of connected clinical sensors for participant monitoring and data collection
Configurable dashboards provide real-time participant tracking and trial progress to sites and sponsors
Participant support & engagement
Connect with trial participants and deliver the resources they need, wherever they are.
Our virtual team can augment your study staff to assist with onboarding, adherence tracking, and technical support
Integrated app equips participants with educational and clinical resources
Logistics services that deliver complete device life cycle management
Regulatory & Compliance
Scalable product development services and workflows enhance privacy and security.
Consulting and roadmap for novel algorithm regulatory clearance
Validation strategies for digital biomarkers and digital endpoints
Experience with global regulatory authorities to support trials across regions and countries
Platform built to comply with global regulations, including FDA 21 CFR Part 11, ICH E6 (R2), and GDPR
Data Science
Turn physiologic data into digital biomarkers and algorithms that help enhance clinical insights and personalize care.
Multi-variate analysis of physiological parameters to detect physiological changes from patient’s own baseline
Drug-specific model training to measure disease progression and detect exacerbation
Setting the standard for digital clinical trials
Configurable platform
Cloud-based infrastructure and data science capabilities serve as the foundation for personalized and scalable solutions that adapt to the needs of your clinical trial programs.
Cellular-enabled device integrations for continuous and episodic data collection
Machine-learning analytics engine for development of digital biomarkers
In-home services coordination capabilities
User-friendly dashboard and communication interface for participants and trial personnel
Remote patient management
Extend trial participation beyond traditional settings, with solutions that enable hybrid or fully decentralized programs.
Digital patient tools including eConsent, ePRO, remote data capture, and virtual visits
Device-agnostic ecosystem of connected clinical sensors for participant monitoring and data collection
Configurable dashboards provide real-time participant tracking and trial progress to sites and sponsors
Participant support & engagement
Connect with trial participants and deliver the resources they need, wherever they are.*
Our virtual team can augment your study staff to assist with onboarding, adherence tracking, and technical support
Integrated app equips participants with educational and clinical resources
Logistics services that deliver complete device lifecycle management
Regulatory & Compliance
Scalable product development services and workflows enhance privacy and security.
Consulting and roadmap for novel algorithm regulatory clearance
Validation strategies for digital biomarkers and digital endpoints
Experience with global regulatory authorities to support trials across regions and countries
Platform built to comply with global regulations, including FDA 21 CFR Part 11, ICH E6 (R2), and GDPR
Data science
Turn physiologic data into digital biomarkers and algorithms that help enhance clinical insights and personalize care.
Multi-variate analysis of physiological parameters to detect physiological changes from individual's own baseline
Drug-specific model training to measure disease progression and detect exacerbation
Solutions
Digital Clinical Trials
Onboard, manage, and communicate remotely with participants leveraging fully customizable solutions that include tools to support workflow efficiency, expand trial access, and enhance data capture.
eConsent
Sensor-integrated ePRO
Televisits and bi-directional communications
Continuous, remote data collection
In-home service coordination
Device kitting and logistics
Digital drug companions
Technology and support services to promote participant engagement and retention.
Participant app inclusive of communications tools, medication and activity reminders, surveys, and educational content
Configurable dashboards with real-time participant oversight to identify trends
Clinical support services to assist with onboarding, engagement, and adherence tracking
Digital measures, biomarkers, and endpoints
Harness physiologic data to develop algorithms that can help enhance therapies and provide further patient insights, leading to more informed patient strategies.
Continuous and episodic data collection enabled by our device-agnostic ecosystem of clinical sensors
Digital biomarker development
Novel digital endpoint design
Algorithm design, validation, and roadmap towards regulatory clearance (SaMD)
Interested in learning more?
Schedule A CallShaping a more healthful future
.svg)
We’ve partnered with Chugai to develop digital tools that objectively measure pain to personalize care for patients with endometriosis.
.svg)
With Vanderbilt University, we’re investigating remote monitoring and early detection of adverse events in cancer patients receiving CAR-T therapy.
*Subject to geography and connectivity